A province known for policy brinkmanship now stood on the verge of testing whether a different balance between public insurance and private delivery could rescue a cherished system from its own inertia, and the implications for wait times, professional recruitment, and intergovernmental politics
Against the steady rise in cancer’s complexity and symptom burden, oncology nurses occupy a vantage point that allows early palliative care to move from a late-stage rescue to a standard, proactive layer of support woven throughout treatment, recovery, and survivorship. Their continuity at the
In clinics where every minute and dollar count, a screening tool built on routine blood work and machine learning promises to move patients faster toward answers and treatment by turning familiar lab values into early signals of tuberculosis risk that are cheap to collect, easy to interpret, and
A crowded domestic arena, tighter pricing from centralized procurement, and a surge of installed capacity have converged to push Chinese medical device makers to reframe growth not as a volume race but as a brand-and-compliance contest in higher-value global niches. The latest data picture
The healthcare industry stands at a crucial turning point, where the traditional dependence on fee-for-service (FFS) models clashes with the growing emphasis on value-based care (VBC) principles, creating a complex challenge for hospitals. As key components of the system, hospitals grapple with a
In a transformative move that could redefine the landscape of medical technology procurement in the United Kingdom, NHS Supply Chain (NHSSC) has embarked on a strategic pivot toward a more selective framework for sourcing MedTech products, marking a significant departure from the traditional broad,
